Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1992 1
1993 1
1994 2
1998 1
1999 1
2001 2
2002 5
2003 3
2004 3
2005 4
2006 2
2007 2
2008 3
2009 4
2010 8
2011 4
2012 5
2013 5
2014 9
2015 8
2016 7
2017 7
2018 6
2019 18
2020 16
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.
Keller MD, Harris KM, Jensen-Wachspress MA, Kankate VV, Lang H, Lazarski CA, Durkee-Shock J, Lee PH, Chaudhry K, Webber K, Datar A, Terpilowski M, Reynolds EK, Stevenson EM, Val S, Shancer Z, Zhang N, Ulrey R, Ekanem U, Stanojevic M, Geiger A, Liang H, Hoq F, Abraham AA, Hanley PJ, Cruz CR, Ferrer K, Dropulic L, Gangler K, Burbelo PD, Jones RB, Cohen JI, Bollard CM. Keller MD, et al. Among authors: hanley pj. Blood. 2020 Dec 17;136(25):2905-2917. doi: 10.1182/blood.2020008488. Blood. 2020. PMID: 33331927 Free PMC article.
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
McLaughlin LP, Rouce R, Gottschalk S, Torrano V, Carrum G, Wu MF, Hoq F, Grilley B, Marcogliese AM, Hanley PJ, Gee AP, Brenner MK, Rooney CM, Heslop HE, Bollard CM. McLaughlin LP, et al. Among authors: hanley pj. Blood. 2018 Nov 29;132(22):2351-2361. doi: 10.1182/blood-2018-07-863654. Epub 2018 Sep 27. Blood. 2018. PMID: 30262660 Free PMC article. Clinical Trial.
SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein.
Keller MD, Harris KM, Jensen-Wachspress MA, Kankate V, Lang H, Lazarski CA, Durkee-Shock JR, Lee PH, Chaudhry K, Webber K, Datar A, Terpilowski M, Reynolds EK, Stevenson E, Val S, Shancer Z, Zhang N, Ulrey R, Ekanem UO, Stanojevic M, Geiger AE, Liang H, Hoq F, Abraham AA, Hanley PJ, Cruz CRY, Ferrer K, Dropulic L, Gangler K, Burbelo PD, Jones RB, Cohen JI, Bollard CM. Keller MD, et al. Among authors: hanley pj. Blood. 2020 Oct 26:blood.2020008488. doi: 10.1182/blood.2020008488. Online ahead of print. Blood. 2020. PMID: 33104167
Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study.
Hont AB, Cruz CR, Ulrey R, O'Brien B, Stanojevic M, Datar A, Albihani S, Saunders D, Hanajiri R, Panchapakesan K, Darko S, Banerjee P, Fortiz MF, Hoq F, Lang H, Wang Y, Hanley PJ, Dome JS, Bollard CM, Meany HJ. Hont AB, et al. Among authors: hanley pj. J Clin Oncol. 2019 Sep 10;37(26):2349-2359. doi: 10.1200/JCO.19.00177. Epub 2019 Jul 29. J Clin Oncol. 2019. PMID: 31356143 Free PMC article. Clinical Trial.
Driving the CAR to the Bone Marrow Transplant Program.
Dave H, Jerkins L, Hanley PJ, Bollard CM, Jacobsohn D. Dave H, et al. Among authors: hanley pj. Curr Hematol Malig Rep. 2019 Dec;14(6):561-569. doi: 10.1007/s11899-019-00544-6. Curr Hematol Malig Rep. 2019. PMID: 31643018 Review.
125 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page